Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma

Hepato-Gastroenterology

Volumn 56, Issue 93, 2009, Pages 1039-1043

  Shimada, Hideaki ^a   Okazumi, Shinichi ^a   Shiratori, Tooru ^a   Akutsu, Yasunori ^a   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Prognostic factor; Squamous cell carcinoma; T2; T3; Thoracic esophageal cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; ESOPHAGUS TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 70350506120     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Shimada H, Matsubara H, Okazumi S, et al.: Improved surgical results in thoracic esophageal squamous cell carcinoma: A 40-year analysis of 792 patients. J Gastrointest Surg. 2008; 12:518-526.
2. Akiyama H, Tsurumaru M, Udagawa H, et al.: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220:364-373. (Pubitemid 24313229)
3. Altoki N, Kent M, Ferrara C, et al.: Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002; 236:177-183. (Pubitemid 34809536)
4. Shimada H, Okazumi S, Matsubara H, et al.: Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 2006; 30:1441-1449. (Pubitemid 44421246)
5. Tachibana M, Kinugasa S, Yoshimura H, et al.: Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005; 189:98-109. (Pubitemid 40215515)
6. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 2007; 11:1384-1393.
7. Wijnhoven BP, Tran KT, Esterman A, et al.: An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007; 245:717-725. (Pubitemid 46684101)
8. Shimada Y, Imamura M, Sato F, et al.: Indications for abdominal para-aortic lymph node dissection in patients with esophageal squamous cell carcinoma. Surgery. 2002; 132:93-99. (Pubitemid 34787827)
9. Kato H, Udagawa H, Togo A, et al.: A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group study (JCOG9708). Proc Am Soc Clin Oncol 2003; 22:1147.
10. Ura T, Muro K, Shimada Y, et al.: Definitive chemoradiotherapy may be standard treatment options in clinical stage I esophageal cancer. Proc Am Soc Clin Oncol 2004; 22:4017.
11. Law S, Kwong DL, Kwok KF, et al.: Improvement in treatment results and long-term survival of patients with esophageal cancer. Impact of chemoradiation and change in treatment strategy. Ann Surg 2003; 238:339-347.
12. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185:538-543. (Pubitemid 36627845)
13. Gebski V, Burmeister B, Smithers BM, et al.: Australasian Gastro-Intestinal Trials GroupSurvival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007; 8:226-234. (Pubitemid 46291702)
14. Igaki H, Kato H, Tachimori Y, et al.: Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery 2003; 133:368-374. (Pubitemid 36515324)
15. Igaki H, Kato H, Tachimori Y, et al.: Surgery for clinical T3 carcinoma of the upper thoracic oesophagus and the need for new strategies. Br J Surgery 2005; 92:1235-1240. (Pubitemid 41475233)
16. Sobin LH, Wittekind CH (eds) UICC TNM Classification of malignant tumor. 6th ed. New York: A John Wiley & Sons, Inc.; 2002.
17. Japanese Society for Esophageal Diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: Preface, general principals, part I. Esophagus 2004; 1:61-88.
18. Okazumi S, Ochiai T, Shimada H, et al.: Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 2004; 17:159-163. (Pubitemid 39076939)
19. Shimada H, Okazumi S, Matsubara H, et al.: Is the surgical stress associated with worse survival in patients with esophageal cancer? - Analysis of colon substitution for 37 patients with remnant stomach. Hepatogastroenterology 2007; 54:791-795. (Pubitemid 46903725)
20. Shimada H, Ochiai T, Okazumi S, et al.: Clinical benefits of steroid on the surgical stress in patients with esophageal cancer. Surgery 2000; 128:791-798.
21. Shimada H, Kitabayashi H, Nabeya Y, et al.: Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003; 133:24-31. (Pubitemid 36183122)